Прекращено
Фаза III
Россия
Octreotide Implant; Sandostatin LAR Depot · Endo USA Inc., a Keenova Therapeutics Company
Phase III, Open-Label, Multicenter International Study to Evaluate the Efficacy and Safety of an Octreotide Implant vs. Sandostatin LAR Depot in Patients With Acromegaly